PharmaEssentia Corporation (LUX:261280523)
15.60
-1.20 (-7.14%)
At close: Mar 31, 2025
PharmaEssentia Revenue
In the year 2024, PharmaEssentia had annual revenue of 9.73B TWD with 90.67% growth. PharmaEssentia had revenue of 3.06B in the quarter ending December 31, 2024, with 85.90% growth.
Revenue
9.73B TWD
Revenue Growth
+90.67%
P/S Ratio
n/a
Revenue / Employee
74.31M TWD
Employees
131
Market Cap
4.96B EUR
Revenue Chart
* This company reports financials in TWD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.73B | 4.63B | 90.67% |
Dec 31, 2023 | 5.11B | 2.22B | 77.15% |
Dec 31, 2022 | 2.88B | 2.23B | 339.00% |
Dec 31, 2021 | 656.51M | 99.25M | 17.81% |
Dec 31, 2020 | 557.26M | 251.57M | 82.29% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reinet Investments S.C.A. | 1.04B |
Luxempart | 50.29M |
CPI FIM | 147.67M |
Socfinasia | 178.94M |
Socfinaf | 550.77M |
Velcan Holdings | 3.01M |
GP Investments | 96.12M |